Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | SLC6A8 |
Upstream (Parents) |
---|
(<<) METTL7A → SLC6A8 |
(<<) LOC653562///SLC6A10P///SLC6A8 → SLC6A8 |
(<<) ALDOA → SLC6A8 |
(<<) ENO2 → SLC6A8 |
(<<) TUFT1 → SLC6A8 |
Downstream (Children) |
---|
SLC6A8 → RBMS2 (>>) |
SLC6A8 → PDE1B (>>) |
SLC6A8 → LOC647288 (>>) |
SLC6A8 → ADM (>>) |
SLC6A8 → LOC653562///SLC6A10P///SLC6A8 (>>) |
SLC6A8 → GNL3LP1 (>>) |
SLC6A8 → TRAJ17///TRAV20///TRD@///TRA@ (>>) |
SLC6A8 → ERO1L (>>) |
SLC6A8 → RPS6KA6 (>>) |
SLC6A8 → KRT33B (>>) |
SLC6A8 → BHLHE40 (>>) |
SLC6A8 → BCL9 (>>) |
SLC6A8 → HPCAL4 (>>) |